US Merger & Acquisition SEC Filings — July 24, 2026

24-07-2026

Perceptive Capital Solutions Corp (PCSC) completed its business combination with Freenome, Inc. on July 23, 2026, with Freenome as the accounting acquirer. The combined entity, renamed Freenome, Inc., issued 107.4 million pro forma common shares, with Freenome equity holders owning 63.4%. The transaction included a $240 million PIPE investment and conversion of a Roche convertible note. Pro forma cash and cash equivalents total $332.6 million, but the combined company has an accumulated deficit of $1.45 billion.

• · Freenome equity holders hold 63.4% of pro forma common stock; PCSC public stockholders 6.0%; sponsor shares 2.3%; PIPE investors 22.3%; Roche convertible note 6.0%.
• · Pro forma total assets: $722.6 million; total liabilities: $335.3 million.
• · Freenome historical accumulated deficit as of March 31, 2026 was $1.41 billion; pro forma accumulated deficit is $1.45 billion.
• · PCSC had $92.7 million in trust account before redemptions; $8.2 million redeemed for extension and $15.1 million at closing.
• · Freenome had $102.1 million in short-term marketable securities and $156.9 million in property and equipment as of March 31, 2026.

24-07-2026

AMR Resources Acquisition Corp. completed its IPO on July 20, 2026, selling 26,000,000 units at $10.00 each for gross proceeds of $260,000,000, including partial exercise of the underwriters' over-allotment option. Simultaneously, the company raised an additional $7,075,000 through a private placement of 707,500 units to the sponsor and underwriters. The net proceeds are held in a trust account to fund a future business combination, with the company focusing on targets in the mineral resources sector but not yet having identified any specific target.

• · The company is a blank check company (SPAC) incorporated in the Cayman Islands on December 16, 2025.
• · The company has not yet selected any specific business combination target and has not engaged in any substantive discussions with any target.
• · The company intends to focus on target businesses in the mineral resources sector but may pursue opportunities in any industry.
• · As of July 20, 2026, the company had not commenced any operations and will not generate operating revenues until after a business combination.
• · The company has an accumulated deficit of $8,220,611 and a total shareholders' deficit of $8,219,581.
• · Transaction costs totaled $15,008,723, including $5,200,000 in cash underwriting fees, $9,100,000 in deferred underwriting fees, and $708,723 in other offering costs.
• · The trust account holds $260,000,000 ($10.00 per unit) from the IPO proceeds.
• · The underwriters partially exercised their over-allotment option for 1,000,000 units; 2,750,000 units remain unexercised.
• · As a result of the partial over-allotment exercise, 333,333 founder shares are no longer subject to surrender, and 916,667 founder shares remain subject to surrender.
• · The company's Class A ordinary shares, warrants, and units are listed on The Nasdaq Stock Market LLC under symbols AMAC, AMACW, and AMACU, respectively.

24-07-2026

Berkshire Hathaway completed its acquisition of Taylor Morrison Home Corp for $72.50 per share in cash, representing a total equity value of approximately $6.8 billion and total enterprise value of approximately $8.5 billion. Taylor Morrison will be integrated with Berkshire's site-built homebuilding operations (Clayton Properties Group) and will continue to be led by CEO Sheryl Palmer. The combined entity delivered nearly 23,000 home closings in 2025, operates in 21 states and 52 housing markets, and is positioned as the fourth largest homebuilding operation in the U.S.

• · Taylor Morrison has been recognized as America's Most Trusted Builder by Lifestory Research since 2016.
• · Taylor Morrison was honored as one of Fortune's World's Most Admired Companies in 2026.
• · The combined entity serves renters, entry-level, move-up, and resort lifestyle segments.

24-07-2026

Acura Pharmaceuticals, Inc. filed an 8-K to disclose an amended loan schedule under a Secured Promissory Note originally dated November 10, 2022 with Abuse Deterrent Pharma, LLC. The amendment adds 63 additional loans totaling $10,894,279 in aggregate principal, including $2,319,279 from the original note and $7,075,000 from prior loans (Loans #1 through #50) plus $1,500,000 in new loans (Loans #51 through #63) advanced between January and July 2026. The filing reflects ongoing debt financing but does not indicate a merger or acquisition.

• · The amended loan schedule includes 63 loans in total, with the original note dated November 10, 2022.
• · New loans (Loans #51 through #63) were advanced in 2026, with individual amounts of $100,000 or $200,000 each.
• · The filing is dated July 24, 2026, but the amendment was signed on July 20, 2026.

24-07-2026

Renatus Tactical Acquisition Corp I appointed Lauren Selig as a director effective July 21, 2026, and to its Audit, Compensation, and Nominating and Corporate Governance Committees. Ms. Selig brings over 25 years of experience in entertainment, technology, AI, blockchain, and venture investments. She will not receive cash compensation but will be issued 50,000 Class B ordinary shares by the sponsor as compensation.

• · Ms. Selig was appointed to the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.
• · She has entered into an indemnity agreement and a letter agreement on the same terms as those entered into by directors and officers at the time of the IPO.
• · Ms. Selig has agreed to vote any Class A Ordinary Shares held by her in favor of the Company's initial business combination and to facilitate liquidation if a business combination is not consummated within 24 months (or up to 30 months by Board resolution).
• · There are no family relationships between Ms. Selig and any other director or executive officer, and she was not selected pursuant to any arrangement with any person.
• · Ms. Selig has not engaged in any related party transaction reportable under Item 404(a) of Regulation S-K.

24-07-2026

Range Capital Acquisition Corp. disclosed a $60,000 drawdown on July 23, 2026, from its unsecured promissory note with its sponsor, bringing the total outstanding to $120,000. The funds were deposited into the trust account to support the company's ongoing search for an initial business combination. The note, which allows for up to $540,000 in total draws, is non-interest bearing and repayable upon consummation of a business combination or winding up.

• · The note was originally issued on June 18, 2026, as previously reported in an 8-K filed June 25, 2026.
• · The note is unsecured, non-interest bearing, and repayable only from amounts outside the trust account if no business combination is consummated.
• · The issuance was made under the Section 4(a)(2) exemption from registration.

24-07-2026

KULR Technology Group sold approximately 333 BTC for ~$21.5 million (weighted average price ~$64,538/BTC) between July 9-23, 2026, using net proceeds to fully repay its $20.0 million Coinbase credit facility. The company now holds ~760 BTC and maintains a largely debt-free balance sheet, though it has reduced its bitcoin exposure by about 30% from prior levels.

• · Bitcoin sales occurred from July 9 through July 23, 2026.
• · Accrued interest on the credit facility will be calculated at month-end and paid in August 2026.
• · The company's newly appointed Board and CFO were involved in the decision.
• · Remaining net proceeds will be used for general corporate purposes.